PlexusDx provides access to compounded GLP-1 therapies with personalized dosing protocols designed to match your individual response
According to NICE guidance (NG203), any patient with diabetes experiencing an acute deterioration in renal function should have a comprehensive assessment, including review of all medications, hydration status, and potential nephrotoxic exposures
The tool allows patients to report the drug, dose and pharmacy where they find a supply of GLP-1 medications, and to report shortages that can be automatically sent to the Food and Drug Administration (FDA)
The pattern across all of these is consistent: interesting preclinical data, limited human evidence and a massive gap between may modulate GLP-1 signaling in a cell study and produces meaningful clinical weight loss in humans. What to Avoid: Supplements vs Compounded Drugs and Marketing Red Flags The GLP-1 supplement space is flooded with products using manipulative marketing
Achieve a remarkable 10% body weight loss with consistent use over six months or more
Cell Prolif 52 (3), e12575